Your browser doesn't support javascript.
loading
Provider documentation of electronic nicotine delivery systems use among patients prescribed contraception at an academic health center in the Southeastern United States.
Theophilopoulos, Joanna M; LeLaurin, Jennifer H; Williams, Maribeth; Bright, Melissa; Thompson, Lindsay A; Salloum, Ramzi G.
Afiliación
  • Theophilopoulos JM; College of Medicine, University of Florida, Gainesville, FL, USA.
  • LeLaurin JH; Department of Health Outcomes and Biomedical Informatics, College of Medicine, University of Florida, USA.
  • Williams M; Department of Community Health and Family Medicine, College of Medicine, University of Florida, USA.
  • Bright M; Department of Obstetrics and Gynecology, College of Medicine, University of Florida, USA.
  • Thompson LA; Department of Pediatrics, College of Medicine, University of Florida, USA.
  • Salloum RG; Department of Health Outcomes and Biomedical Informatics, College of Medicine, University of Florida, USA.
Prev Med Rep ; 24: 101632, 2021 Dec.
Article en En | MEDLINE | ID: mdl-34976685
PURPOSE: Women on combined hormonal contraception (CHC) who use electronic nicotine delivery systems (ENDS) may be vulnerable to adverse cardiovascular events. To date, no study has examined whether clinicians screen for ENDS use when prescribing CHC. Therefore, we investigated documentation of ENDS screening and counseling in the electronic health record (EHR) of women prescribed CHC. METHODS: We conducted a retrospective EHR review and content analysis at an academic health center in the Southeastern United States. We randomly selected 500 records of female patients 12 years and older who had been prescribed contraception and had ENDS documented in their records identified via keyword match. Records prior to July 2020 were reviewed between June-September 2020. RESULTS: Of the 500 patients, 245 (49%) were ENDS users and 227 (45.4%) were non-ENDS users. Among ENDS users, there were 82 contraception-related encounters with ENDS documentation. In 55 (67.1%) of these encounters, only ENDS use status was documented. The provider counseled against ENDS use in 17 (20.7%) records. Six (7.3%) notes documented provision of patient education materials instructing patients on contraception to refrain from using ENDS. Among non-ENDS users, there were 43 contraception-related encounters with ENDS documentation; 35 (81.4%) documented the patient did not use ENDS and 3 (7%) documented provision of patient education materials. CONCLUSION: ENDS use is under-documented in contraception-related encounters. Improvements in documentation may help assess long-term effects of concurrent ENDS and CHC use. These results illustrate the need to clarify EHR prompts and increase provider awareness to improve ENDS documentation.
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Prev Med Rep Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Prev Med Rep Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos